Thackray Helen M. 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Apr 2, 2024
Insider Transaction Report
Form 4
Thackray Helen M.
Chief R&D Officer
Transactions
- Tax Payment
Common Stock
2024-03-31$5.08/sh−7,525$38,227→ 242,139 total
Footnotes (1)
- [F1]Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.